News‎ > ‎Full Stories‎ > ‎

31 August 2017

posted Aug 31, 2017, 4:24 AM by Beck Lockwood   [ updated Oct 13, 2017, 12:21 AM ]
NIHR DEC wins bid to become NIHR Medtech and In Vitro Diagnostic Co-operative

NIHR DEC Leeds has been successful in its bid to become one of the Government’s newly-funded MedTech & In Vitro Diagnostic Co-operatives (MICs).

The new organisation, called NIHR Leeds In Vitro Diagnostics Co-operative (NIHR Leeds IVD Co-operative), will launch on 1 January 2018, and will be led by Professor Gordon Cook, who is taking over as Clinical Director from Professor Peter Selby.

"Leeds hosting this very important infrastructure programme is a fantastic opportunity to bring together several talented researchers in Leeds to interface with industry and academia to impact diagnosis and ultimately benefit patients,” says Professor Cook.” We will build on the excellent work of NIHR DEC (Leeds) moving forward to generating more successful interactions and outcomes.”

The role of NIHR Leeds IVD Co-operative will be to catalyse the generation of high quality evidence on commercially-supplied IVDs that is required by the NHS, industry and other organisations

In particular, NIHR Leeds IVD Co-operative will  focus on four clinical areas that have a high burden of disease and unmet clinical needs:

·         Oncology

·         Musculoskeletal Disease

·         Infection Diagnostics

·         Renal Medicine.

Each theme has the potential for the development of new medical devices or evidence on commercially supplied IVDs which will lead to improvements in healthcare services.

To support the IVD evaluation pathway, NIHR Leeds IVD Co-operative will draw on expertise in health economics, health informatics, clinical trials and multidisciplinary pathology.

NIHR Leeds IVD Co-operative is one of 11 MICs established nationwide to build expertise and capacity in the NHS to develop new medical technologies and provide evidence on commercially-supplied in vitro diagnostic (IVD) tests.

Also successful in its bid to establish a new NIHR Medical Technology and In Vitro Diagnostic Co-operative was Leeds Colorectal Therapies HTC, making Leeds the only institution in the country to host two MICs.

Funding will continue for five years, enabling the MICS to act as centres of expertise, bringing together patients, clinicians, researchers, health commissioners and industry.

Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health, said: “The funding received by the 11 NIHR Medtech and In Vitro Diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”